Mascoma Wealth Management LLC Exelixis, Inc. Transaction History
Mascoma Wealth Management LLC
- $389 Million
- Q1 2025
A detailed history of Mascoma Wealth Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Mascoma Wealth Management LLC holds 100 shares of EXEL stock, worth $3,721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$3,721% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding EXEL
# of Institutions
574Shares Held
253MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.25 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.1 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$872 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$569 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$425 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...